SENP3 mediates the deSUMOylation and degradation of YAP1 to regulate the progression of triple-negative breast cancer

被引：0
|
作者：
Chen, Xu [1 ]
Li, Danqing [1 ]
Su, Qi [1 ]
Ling, Xing [1 ]
Yang, Yanyan [1 ]
Liu, Yuhang [1 ]
Zhu, Xinjie [1 ]
He, Anqi [1 ]
Ding, Siyu [1 ]
Xu, Runxiao [1 ]
Liu, Zhaoxia [1 ]
Long, Xiaojun [1 ]
Zhang, Jinping [2 ]
Yang, Zhihui [2 ]
Qi, Yitao [1 ]
Wu, Hongmei [1 ]
机构：
[1] College of Life Sciences, Shaanxi Normal University, Shaanxi, Xi'an, China
[2] Department of Pathology, The Affiliated Hospital of Southwest Medical University, Sichuan, Luzhou, China
来源：
Journal of Biological Chemistry | 2024年 / 300卷 / 10期
关键词：
Compendex;
D O I：
10.1016/j.jbc.2024.107764
中图分类号：
学科分类号：
摘要：
Stem cells
引用
收藏
相关论文
共 50 条
  • [31] Correlation between the Warburg effect and progression of triple-negative breast cancer
    Liu, Shaojun
    Li, Yuxuan
    Yuan, Meng
    Song, Qing
    Liu, Min
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [32] lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer
    Yu, Haizhen
    Wu, Yang
    Huang, Jianyuan
    Li, Shizhen
    ANTICANCER RESEARCH, 2023, 43 (12) : 5475 - 5483
  • [33] Microarray data reveal potential genes that regulate triple-negative breast cancer
    Pan, Chi
    Cong, Aihua
    Ni, Qingtao
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (10)
  • [34] Immune and metabolic mechanisms regulate the microenvironment in triple-negative breast cancer.
    Andrieu, Guillaume
    Sebastiani, Paola
    Bertrand, Kimberly A.
    Palmer, Julie R.
    Denis, Gerald V.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 90 - 90
  • [35] Breast Cancer Antiestrogen Resistance 3 (BCAR3) promotes tumor growth and progression in triple-negative breast cancer
    Arras, Janet
    Thomas, Keena S.
    Myers, Paul J.
    Cross, Allison M.
    Osei, Amare D.
    Vazquez, Gabriel E.
    Atkins, Kristen A.
    Conaway, Mark R.
    Jones, Marieke K.
    Lazzara, Matthew J.
    Bouton, Amy H.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (10): : 4768 - 4787
  • [36] Macropinocytosis mediates resistance to loss of glutamine transport in triple-negative breast cancer
    Kanu Wahi
    Natasha Freidman
    Qian Wang
    Michelle Devadason
    Lake-Ee Quek
    Angel Pang
    Larissa Lloyd
    Mark Larance
    Fabio Zanini
    Kate Harvey
    Sandra O’Toole
    Yi Fang Guan
    Jeff Holst
    The EMBO Journal, 2024, 43 (23) : 5857 - 5882
  • [37] Hypomethylation of ATP1A1 Is Associated with Poor Prognosis and Cancer Progression in Triple-Negative Breast Cancer
    Kim, Yesol
    Ko, Je Yeong
    Kong, Hyun Kyung
    Lee, Minyoung
    Chung, Woosung
    Lim, Sera
    Son, Dasom
    Oh, Sumin
    Park, Jee Won
    Kim, Do Yeon
    Lee, Minju
    Han, Wonshik
    Park, Woong-Yang
    Yoo, Kyung Hyun
    Park, Jong Hoon
    CANCERS, 2024, 16 (09)
  • [38] Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression
    Yamashita, Nami
    Kufe, Donald
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [39] PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression
    Gagliano, Teresa
    Shah, Kalpit
    Gargani, Sofia
    Lao, Liyan
    Alsaleem, Mansour
    Chen, Jianing
    Ntafis, Vasileios
    Huang, Penghan
    Ditsiou, Angeliki
    Vella, Viviana
    Yadav, Kritika
    Bienkowska, Kamila
    Bresciani, Giulia
    Kang, Kai
    Li, Leping
    Carter, Philip
    Benstead-Hume, Graeme
    O'Hanlon, Timothy
    Dean, Michael
    Pearl, Frances M. G.
    Lee, Soo-Chin
    Rakha, Emad A.
    Green, Andrew R.
    Kontoyiannis, Dimitris L.
    Song, Erwei
    Stebbing, Justin
    Giamas, Georgios
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (06): : 3188 - 3204
  • [40] CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A
    Dandan Feng
    Jie Gao
    Ruiqiong Liu
    Wei Liu
    Tianyang Gao
    Yunkai Yang
    Die Zhang
    Tianshu Yang
    Xin Yin
    Hefen Yu
    Wei Huang
    Yan Wang
    Protein & Cell, 2024, 15 (10) : 744 - 765
12345